Selected Essay on Quality Month of Pharmaceutical Company
Release time:
2022-12-04
drugs
during the national day, a relative in the village came to me with two boxes of metformin hydrochloride englijing tablets, saying that one of his two boxes of drugs was prepared by the hospital and the other was bought at the pharmacy. The drugstore recommended another one because it did not have the kind that the hospital matched, saying that the effect was the same, but he always felt that the effect was not good after taking it back and wanted to ask whether the psychological effect or the drug effect was really different.
For most drug users, the intuitive effect after taking drugs is all the drug quality connotation they can understand. The drug market is full of flowers. There are dozens or even hundreds of manufacturers of the same drug. It is really difficult for consumers to judge which is better. In order to improve the quality of drugs, pharmaceutical manufacturers need to ensure their effectiveness, safety, stability and uniformity to the greatest extent. In addition, through the reasonable control of production costs, the market competitiveness of products should be enhanced to ensure the economy of drug use by consumers. On my first day at the pharmaceutical factory, I was trained on the concept of
"drug quality is not tested, but produced " . In my work practice, I have deeply realized that the quality of drugs is not only based on the test results, but also on the test reports. Changes, deviations, complete quality system, qualified production personnel, raw materials provided by qualified suppliers, confirmed production equipment, good environment, and standardized implementation of production operating procedures, each link is an important part of drug quality. Any changes in production, any fluctuations that deviate from established parameters, need to be addressed through risk assessment. There is a long way to go to ensure the quality of drugs and ensure the life, health and safety of the drug user. The peak is making continuous efforts and striving forward ... With the encouragement of innovative drugs at the national policy level and the comprehensive promotion of drug consistency evaluation, drug manufacturers are facing the survival of the fittest, and the phenomenon of good and bad drugs on the market will come to an end. As a member of the drug production process, I will do my best to work with other members of the team to earnestly perform my duties and effectively ensure the safety of each drug. I firmly believe that the upcoming development of the peak brand metformin hydrochloride nglijing tablets will become The first choice for the majority of diabetic patients.
(Ye Ke, Workshop G01
, Xinjinxi Factory Area)During the quality activity month of Flight Inspection
, the pharmaceutical company carried out a series of colorful activities around quality, such as hanging banners in the factory area, holding knowledge lectures, setting up learning groups, collecting short videos, and answering knowledge.
coincided with the on-site verification of the
CM082project by the national bureau and provincial bureau inspectors during the quality month activities. After the inspection, the person in charge of quality sighed and said: "Our employees are becoming more and more confident when facing the inspection. " Looking back on the inspections experienced these years, I also feel a lot of emotion. When I first checked, I was afraid that the inspector would point out the defects, always thinking that the fewer defects, the better. This incorrect mentality has led me to always worry about gains and losses when facing inspections, and regard reducing the lack of clauses as my first priority. Be complacent because there are few defective clauses, and upset because there are many defective clauses. In the face of inspection will be anxious, answer the inspector's questions will be nervous, and even afraid to answer questions. After flight inspection and verification, rectification and correction, our quality system is gradually complete. The gradual improvement of the document system also gave me confidence, because every step of the operation and records are based on evidence, and I can answer the inspector's questions in an orderly manner against the internal documents. Slowly, I changed my position from being inspected to being a student, and the inspector was my best teacher. Now, for their own management difficulties, I will take the initiative to consult the teacher, hoping to get some advice from the teacher. The examination teacher will often patiently answer my questions and answer my doubts. Look! The inspector is not so terrible as imagined, but a group of persistent and lovely people.
As the saying goes
"gold is not barefoot, no one is perfect " , there is no perfect enterprise in the world, and every enterprise has some defects and deficiencies more or less. As long as we do our job well, do not cheat or cheat, sincerely and humbly listen to the teacher's teachings, frankly accept the defects pointed out by the teacher, understand and actively and thoroughly rectify, our quality management will become more and more comprehensive. However, there is no end to quality management. It still requires generations of quality people to strengthen their beliefs, face quality management with the spirit of craftsmen, and contribute their own strength to achieve a century-old peak. We 've been on the road! ( QC
A Fu Junli)My post and my quality responsibility
The first sight of this topic aroused my deep thinking. As a workshop manager, facing the production line, how should the quality responsibility of this post be reflected and continued? In fact, the quality responsibility of the post is the responsibility of the whole staff, while I play the role of supervising, executing, summarizing, deepening and training the executor of a circular process.
, as the executor, should fully interpret the contents of the existing documents, sort out the key quality control points of each product, each post and each equipment operation from the documents, and strengthen the memory of the operators in the training, so as to avoid the existing irregularities that have been found and have countermeasures as much as possible in the subsequent production. For example, according to the pipeline design of the preparation system, it is necessary to confirm that the bottom valve of the tank is closed before use after cleaning and sterilization. If it is not closed, the preparation operation should be stopped, and there are regulations in the document and records should be formed to effectively prevent leakage accidents.
Secondly, during the inspection process, with the interpretation of existing documents, communicate effectively with employees, and analyze potential problems in the production operation process such as process and equipment from the perspective of employees, or problems that employees have found but have not formed documents and records. For example, the newly purchased high-speed labeling machine of eye drops production line, after communicating with the operators during the on-site inspection of the production process, found that attention should be paid to whether the labeling position and printing position of the label drift after label replacement. After the ribbon is replaced, check and confirm the printing effect and whether the ribbon position is not correct. When the production process is stopped, the roller products entering the labeling machine need to be empty. There is no description of relevant contents in the troubleshooting of
manufacturer's data. They are all summarized by the workshop according to the actual operation process and confirm whether other labeling machines have the same problems. These precautions are added to the standard operating procedures of labeling machines to prevent the occurrence of such problems. The same applies to other equipment. During operation, attention should be paid to whether changes will be caused by similar replacement of packaging materials, materials or components.
Finally, as managers, they should make an in-depth analysis of the problems found in the inspection, add inspection or operation contents to the corresponding documents and records after summarizing, then carry out timely training, and confirm the implementation and elimination measures in the future inspection. In this way, a cycle of supervision, implementation, summary, deepening and training is formed, and the quality responsibility is continued in the form of documents and records.
The responsibility for quality is endless, and it is always necessary to set the quality policy of the enterprise
"" to pursue excellent quality; to be a high-quality medicine for the benefit of human society! "is printed in the mind, keep learning and updating, and be the continuator of quality responsibility! (Preparation Workshop
Fang Ling)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31